Clinical studies on GLP-1 compounds show dose-dependent effects, meaning lower doses produce measurable appetite suppression and metabolic benefitstypically 8-12% weight loss over 6-12 months at microdose levels
The chart eliminates the mental math, the second-guessing, the late-night recalculations after you realize something might be off
And that brings us right back to the stomach
Unlike some medications that must be taken with food or on an empty stomach, tirzepatide can be administered regardless of when you last ate
Both require insurance or significant out-of-pocket costs, often $900$1,300 monthly, and face widespread shortages
However, development of GIPR- and GCGR-based therapeutics has encountered drawbacks due to the complexity of physiology associated with GIP and GCG 4,5,6